Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H17ClN3O3P |
Molecular Weight | 413.794 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CO[P@](=O)(C1=C(NC2=CC=C(Cl)C=C12)C(N)=O)C3=CC(\C=C\C#N)=CC(C)=C3
InChI
InChIKey=CGBYTKOSZYQOPV-CCEZBSFNSA-N
InChI=1S/C20H17ClN3O3P/c1-12-8-13(4-3-7-22)10-15(9-12)28(26,27-2)19-16-11-14(21)5-6-17(16)24-18(19)20(23)25/h3-6,8-11,24H,1-2H3,(H2,23,25)/b4-3+/t28-/m0/s1
Molecular Formula | C20H17ClN3O3P |
Molecular Weight | 413.794 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
PubMed
Title | Date | PubMed |
---|---|---|
Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease. | 2010 Oct 15 |
|
Central nervous system disposition and metabolism of Fosdevirine (GSK2248761), a non-nucleoside reverse transcriptase inhibitor: an LC-MS and Matrix-assisted laser desorption/ionization imaging MS investigation into central nervous system toxicity. | 2013 Feb 18 |
|
Unexpected finding of delayed-onset seizures in HIV-positive, treatment-experienced subjects in the Phase IIb evaluation of fosdevirine (GSK2248761). | 2014 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:27:56 GMT 2023
by
admin
on
Fri Dec 15 18:27:56 GMT 2023
|
Record UNII |
Z4I0C281BJ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
WW-17
Created by
admin on Fri Dec 15 18:27:56 GMT 2023 , Edited by admin on Fri Dec 15 18:27:56 GMT 2023
|
PRIMARY | |||
|
Z4I0C281BJ
Created by
admin on Fri Dec 15 18:27:56 GMT 2023 , Edited by admin on Fri Dec 15 18:27:56 GMT 2023
|
PRIMARY | |||
|
C170008
Created by
admin on Fri Dec 15 18:27:56 GMT 2023 , Edited by admin on Fri Dec 15 18:27:56 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104968
Created by
admin on Fri Dec 15 18:27:56 GMT 2023 , Edited by admin on Fri Dec 15 18:27:56 GMT 2023
|
PRIMARY | |||
|
100000174902
Created by
admin on Fri Dec 15 18:27:56 GMT 2023 , Edited by admin on Fri Dec 15 18:27:56 GMT 2023
|
PRIMARY | |||
|
DTXSID501031227
Created by
admin on Fri Dec 15 18:27:56 GMT 2023 , Edited by admin on Fri Dec 15 18:27:56 GMT 2023
|
PRIMARY | |||
|
9289
Created by
admin on Fri Dec 15 18:27:56 GMT 2023 , Edited by admin on Fri Dec 15 18:27:56 GMT 2023
|
PRIMARY | |||
|
1018450-26-4
Created by
admin on Fri Dec 15 18:27:56 GMT 2023 , Edited by admin on Fri Dec 15 18:27:56 GMT 2023
|
PRIMARY | |||
|
44224276
Created by
admin on Fri Dec 15 18:27:56 GMT 2023 , Edited by admin on Fri Dec 15 18:27:56 GMT 2023
|
PRIMARY | |||
|
DB06166
Created by
admin on Fri Dec 15 18:27:56 GMT 2023 , Edited by admin on Fri Dec 15 18:27:56 GMT 2023
|
PRIMARY | |||
|
Fosdevirine
Created by
admin on Fri Dec 15 18:27:56 GMT 2023 , Edited by admin on Fri Dec 15 18:27:56 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
TARGET ORGANISM->INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |